Working… Menu
Trial record 47 of 2100 for:    cancer vaccine

QUILT-3.048: NANT Urothelial Cancer Vaccine: Combination Immunotherapy in Subjects With Urothelial Cancer Who Have Progressed on or After Chemotherapy and PD-1/PD-L1 Therapy

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT03197571
Recruitment Status : Withdrawn (Trial not initiated)
First Posted : June 23, 2017
Last Update Posted : March 18, 2021
Information provided by (Responsible Party):
ImmunityBio, Inc.

No Study Results Posted on for this Study
Study was withdrawn before participants were enrolled.
Recruitment Status : Withdrawn
Estimated Primary Completion Date : January 2019
Estimated Study Completion Date : March 2019